Sartorius Stedim Biotech's total assets for Q4 2025 were €8.02B, an increase of 1.75% from the previous quarter. FR:DIM total liabilities were €3.89B for the fiscal quarter, a 2.21% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.